What Globus Medical, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 2 | 13 |
| Total trades | 5 | 26 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 26 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Tobin James R | Director | Sep 15 | Open-market sale · S | −30,000 | $74.58 | −$2.24M | 0 |
| Tobin James R | Director | Sep 15 | Exercise / conversion · M | +15,000 | $63.68 | +$955K | 30,000 |
| Tobin James R | Director | Sep 15 | Exercise / conversion · M | +15,000 | $53.75 | +$806K | 15,000 |
| Zarrilli Stephen T | Director | Aug 18 | Open-market sale · S | −25,000 | $87.04 | −$2.18M | 0 |
| Zarrilli Stephen T | Director | Aug 18 | Exercise / conversion · M | +25,000 | $53.27 | +$1.33M | 25,000 |
| Davidar David D | Director | Jul 27 | Gift · G | −2,500 | — | — | 507,675 |
| Davidar David D | Director | Jun 05 | Open-market sale · S | −25,000 | $80.76 | −$2.02M | 510,175 |
| Davidar David D | Director | Jun 05 | Exercise / conversion · M | +25,000 | $26.27 | +$657K | 535,175 |
| Rhoads Ann D | Director | Jun 04 | Exercise / conversion · M | +25,000 | $26.27 | +$657K | 40,384 |
| Huller Kelly | EVP, GC, Corporate Secretary | Feb 25 | Open-market sale · S | −20,000 | $94.50 | −$1.89M | 0 |
| Huller Kelly | EVP, GC, Corporate Secretary | Feb 25 | Exercise / conversion · M | +20,000 | $43.58 | +$872K | 20,000 |
| Huller Kelly | EVP, GC, Corporate Secretary | Feb 12 | Open-market sale · S | −10,000 | $87.67 | −$877K | 0 |
| Huller Kelly | EVP, GC, Corporate Secretary | Feb 12 | Exercise / conversion · M | +10,000 | $45.64 | +$456K | 10,000 |
| Kline Kyle | Senior Vice President, CFO | Jan 08 | Open-market sale · S | −3,594 | $101.10 | −$363K | 0 |
| Kline Kyle | Senior Vice President, CFO | Jan 08 | Exercise / conversion · M | +3,594 | $51.87 | +$186K | 3,594 |
| Norwalk Leslie V | Director | Jan 08 | Open-market sale · S | −2,000 | $101.10 | −$202K | 10,419 |
| Norwalk Leslie V | Director | Dec 12 | Open-market sale · S | −4,000 | $88.85 | −$355K | 12,419 |
| Paul David C | Executive Chairman | Dec 08 | Exercise / conversion · M | +34,375 | $25.52 | +$877K | 60,417 |
| Huller Kelly | SVP, GC, Corporate Secretary | Nov 25 | Open-market sale · S | −7,500 | $90.00 | −$675K | 0 |
| Huller Kelly | SVP, GC, Corporate Secretary | Nov 25 | Exercise / conversion · M | +7,500 | $25.96 | +$195K | 7,500 |
Loading...
